Herbalife Nutrition Ltd. (HLF) AI Stock Analysis

Herbalife Nutrition Ltd. is a global provider of nutritional products and solutions founded in 1980 and headquartered in Los Angeles, California. The company's portfolio encompasses weight management, targeted nutrition, energy, sports, fitness, and outer nutrition. Offerings include meal replacement shakes, protein mixes, healthy snacks, dietary supplements, functional beverages, and personal wellness products such as skincare and haircare items. Herbalife distributes its products through independent distributors and sales representatives across North America, Europe, Asia Pacific, and Latin America, supported by company-operated retail platforms.

Herbalife saw revenue drop from $5.80B in FY2021 to $5.20B in FY2022, $5.06B in FY2023, and $4.99B in FY2024, contributing to a 5-year revenue CAGR of -1.9% from FY2020 to FY2025. Sales rebounded in FY2025, increasing 0.9% to $5.04B, while net income reached $228.3M and operating margin was 8.8%. In the latest quarter ended June 30, 2026, quarterly revenue grew 5.4% year-over-year and quarterly earnings rose 16.3% year-over-year. Across the trailing twelve months, Herbalife generated $5.20B in revenue, an operating margin of 9.8%, and EPS of $1.57.

As of June 30, 2026, Herbalife had $370.5M in cash and short-term investments alongside total debt of $2.20B, resulting in net debt of $1.83B. Total assets stood at $2.86B against shareholders' equity of -$474.5M, while the current ratio was 1.20. In FY2025, the business produced $333.3M in operating cash flow and $252.9M in free cash flow. Capital allocation in FY2025 included $80.4M for capital expenditures and $8.2M for share buybacks, with its share count increasing 0.9% over 5 years.

Herbalife trades at a trailing P/E of 9.3x and a forward P/E of 3.9x, both below the US-listed Consumer Defensive peer medians of 18.6x and 14.3x. Its EV-to-EBITDA multiple is 5.9x, compared to the peer median of 11.7x, while its price-to-sales ratio is 0.3x versus the peer median of 0.7x. Over the past year, the stock gained 69.6%, outperforming the S&P 500 return of 16.8%. Over a 5-year period, the stock fell 66.4%, while the S&P 500 rose 83.0%.

Wall Street analysts hold 2 StrongBuy, 1 Buy, 0 Hold, and 1 Sell ratings on Herbalife. The mean price target is $17.00, which is 16.4% above the last close price of $14.60. For the fiscal year ending December 31, 2026, analysts estimate EPS of $2.37, representing 11.6% growth, on revenue of $5.26B. Herbalife has beaten consensus EPS estimates in 2 of the last 4 quarters, with its next earnings announcement scheduled for November 2, 2026.

This page is an AI-written research summary of Herbalife Nutrition Ltd. (HLF). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: HLF income statement, HLF balance sheet, HLF key metrics, HLF analyst forecast, HLF chart. See the HLF stock overview for the latest quote and news.